Modulación en la expresión de receptores tipo Toll (TLR) 2 y 4 en neutrófilos y monocitos y disminución de citocinas pro-inflamatorias, tras la administración de un simbiótico, en pacientes con infección por el virus de inmunodeficiencia humana
Luz Alicia González-Hernández(Universidad de Guadalajara), Jaime Andrade‐Villanueva(Hospital Civil de Guadalajara), Mary Fafutis‐Morris(Universidad de Guadalajara), Karina Esthela Montes-Salcedo(Universidad de Guadalajara), Luis Giovani Valle-Gutiérrez(Universidad de Guadalajara)
Revista Médica MD
January 1, 2011
Cited by 0
Related Papers
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Oral Manifestations Associated with HIV/AIDS Patients
|Medicina|2022|97